{"bill": {"#text": "\n\t", "form": {"current-chamber": {"#tail": "\n\t\t", "#text": "IN THE SENATE OF THE UNITED STATES"}, "#text": "\n\t\t", "congress": {"#tail": "\n\t\t", "#text": "113th CONGRESS"}, "#tail": "\n\t", "legis-num": {"#tail": "\n\t\t", "#text": "S. 867"}, "official-title": {"#tail": "\n\t", "#text": "To amend title XVIII of the Social Security Act to\n\t\t  provide for pharmacy benefits manager standards under the Medicare prescription\n\t\t  drug program, to establish basic audit standards of pharmacies, to further\n\t\t  transparency of payment methodology to pharmacies, and to provide for\n\t\t  recoupment returns to Medicare."}, "session": {"#tail": "\n\t\t", "#text": "1st Session"}, "distribution-code": {"#tail": "\n\t\t", "@display": "yes", "#text": "II"}, "action": {"action-date": {"#tail": "\n\t\t\t", "@date": "20130506", "#text": "May 6, 2013"}, "#tail": "\n\t\t", "action-desc": {"#tail": "\n\t\t", "#text": "\n        ", "committee-name": {"#tail": "\n      ", "@committee-id": "SSFI00", "#text": "Committee on\n\t\t\t Finance"}, "sponsor": {"#tail": " (for himself,\n\t\t\t ", "#text": "Mr. Pryor", "@name-id": "S295"}, "cosponsor": [{"#tail": ", ", "#text": "Mr. Moran", "@name-id": "S347"}, {"#tail": ", and ", "#text": "Mr.\n\t\t\t Wicker", "@name-id": "S318"}, {"#tail": ")\n\t\t\t introduced the following bill; which was read twice and referred to the\n\t\t\t ", "#text": "Mr. Boozman", "@name-id": "S343"}]}, "#text": "\n\t\t\t"}, "legis-type": {"#tail": "\n\t\t", "#text": "A BILL"}}, "@bill-stage": "Introduced-in-Senate", "@dms-id": "A1", "@public-private": "public", "legis-body": {"#tail": "\n", "section": [{"@section-type": "section-one", "#tail": "\n    ", "text": {"#tail": "\n\t\t", "quote": {"short-title": {"#tail": "\n        ", "#text": "Medicare Prescription Drug Program\n\t\t\t Integrity and Transparency Act of 2013"}, "#tail": ".", "#text": "\n          "}, "#text": "This Act may be cited as\n\t\t\t the ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "1."}, "header": {"#tail": "\n      ", "#text": "Short\n\t\t\t title"}, "#text": "\n      ", "@id": "S1"}, {"#tail": "\n  ", "enum": {"#tail": "\n      ", "#text": "2."}, "header": {"#tail": "\n\t\t\t", "#text": "Pharmacy\n\t\t\t benefits manager standards under the Medicare program"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ") is amended by adding at the end the following new\n\t\t\t paragraphs:", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "Section 1860D\u201312(b) of the Social Security Act", "@value": "Social Security Act/s:1860D\u201312/ss:b"}, {"#tail": "\n          ", "@entity-type": "uscode", "#text": "42 U.S.C.\n\t\t\t 1395w\u2013112(b)", "@value": "usc/42/1395w\u2013112/b"}], "@entity-type": "law-citation", "#text": "\n            "}}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "In\n\t\t\t general"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n        ", "#text": "."}, "#tail": "\n\t\t\t", "paragraph": {"#tail": "\n          ", "subparagraph": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "quote": {"#tail": ") to manage the\n\t\t\t\tprescription drug coverage provided under such plan, or to control the costs of\n\t\t\t\tthe prescription drug coverage under such plan, unless the PBM satisfies the\n\t\t\t\trequirements described in ", "#text": "PBM"}, "#text": "Each contract entered into with a PDP sponsor under this\n\t\t\t\tpart with respect to a prescription drug plan offered by such sponsor shall\n\t\t\t\tprovide that the PDP may not enter into a contract with any pharmacy benefits\n\t\t\t\tmanager (referred to in this paragraph as a ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "subparagraph (B)", "@value": "Medicare Prescription Drug Program Integrity and Transparency Act of 2013/s:1860D-12/ss:b/p:7/sp:B", "@proposed": "true"}}, "enum": {"#tail": "\n              ", "#text": "(A)"}, "header": {"#tail": "\n              ", "#text": "In\n\t\t\t\tgeneral"}, "#text": "\n              ", "@id": "id3C8DE4E4152045A691B0484B0ADB5125"}, {"#tail": "\n          ", "clause": [{"#tail": "\n              ", "subclause": [{"item": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "The PBM (or\n\t\t\t\tauditing entity) shall disclose the amount of each payment recovered pursuant\n\t\t\t\tto the audit to the PDP sponsor with a copy to the pharmacy."}, "enum": {"#tail": "\n                    ", "#text": "(aa)"}, "@id": "id5af3af4e2ea84f089262518c27af4b4d", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Any payment\n\t\t\t\trecovered by the PBM (or auditing entity) pursuant to the audit shall be\n\t\t\t\treturned to the PDP sponsor."}, "enum": {"#tail": "\n                    ", "#text": "(bb)"}, "@id": "id54b745bd56fd438fa3647a3944932b67", "#text": "\n                    "}], "#tail": "\n                ", "enum": {"#tail": "\n                  ", "#text": "(I)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Assuring\n\t\t\t\trecoveries to Medicare"}, "#text": "\n                  ", "@id": "ida795319554ea471381e7c84b9409d900"}, {"item": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "In\n\t\t\t\tthe case the audit involves clinical or professional judgment, the audit shall\n\t\t\t\tbe conducted by, or in consultation with, a pharmacist licensed in the State of\n\t\t\t\tthe audit or the State board of pharmacy."}, "enum": {"#tail": "\n                    ", "#text": "(aa)"}, "@id": "id1e1706e3a3074704a3a9851ffc1d04e0", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "The pharmacy,\n\t\t\t\tpractice site, or other entity may use a nursing home\u2019s medication\n\t\t\t\tadministration record (MAR), the records of a hospital, physician,\n\t\t\t\trehabilitation facility, State-licensed healthcare facility, or other\n\t\t\t\tauthorized practitioner to validate the pharmacy records and any legal\n\t\t\t\tprescription (one that complies with State Board of Pharmacy requirements) may\n\t\t\t\tbe used to validate claims submitted by the pharmacy in connection with\n\t\t\t\tprescriptions, refills, proof of delivery, or changes in prescriptions during\n\t\t\t\tany phase of the audit, including appeal."}, "enum": {"#tail": "\n                    ", "#text": "(bb)"}, "@id": "id3ae52b5a523f4bf09fc672f72059e9c4", "#text": "\n                    "}], "#tail": "\n                ", "enum": {"#tail": "\n                  ", "#text": "(II)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Assuring\n\t\t\t\tclinical decisions in audits"}, "#text": "\n                  ", "@id": "idd2fb4f8b7e384bc986e060d62e9ab1d3"}, {"item": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "The PBM (or\n\t\t\t\tauditing entity) may not apply recordkeeping or other requirements on the\n\t\t\t\tpharmacy that are more stringent than such requirements applied under Federal\n\t\t\t\tlaw or the State law involved."}, "enum": {"#tail": "\n                    ", "#text": "(aa)"}, "@id": "id68d748ddc7c343abaa950df464907202", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "The PBM (or\n\t\t\t\tauditing entity) shall accept all pharmacy prescription records related to the\n\t\t\t\taudit in an electronic format or other digital media."}, "enum": {"#tail": "\n                    ", "#text": "(bb)"}, "@id": "id951fbc3b96584fba988991d109a6aff7", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ". In the case of errors that have\n\t\t\t\tno financial harm to the patient or plan, the PBM shall not assess any\n\t\t\t\tchargebacks.", "@entity-type": "uscode", "#text": "\n                        ", "external-xref": {"#tail": " of title 18, United States Code", "@parsable-cite": "usc/18/1347", "#text": "section 1347", "@legal-doc": "usc"}, "@value": "usc/18/1347"}, "#text": "The PBM (or\n\t\t\t\tauditing entity) may not, pursuant to the audit, disallow the entire payment\n\t\t\t\twith respect to a claim submitted by the pharmacy because of a clerical or\n\t\t\t\trecordkeeping error (such as a typographical error, scrivener's error, or\n\t\t\t\tcomputer error) if there is an absence of intent to commit fraud, as defined in\n\t\t\t\t"}, "enum": {"#tail": "\n                    ", "#text": "(cc)"}, "@id": "id34fa1bac56b943cebf2fa026b8069538", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "The PBM (or\n\t\t\t\tauditing entity) may not use extrapolation or other statistical expansion\n\t\t\t\ttechniques in calculating any recoupment or penalty pursuant to the\n\t\t\t\taudit."}, "enum": {"#tail": "\n                    ", "#text": "(dd)"}, "@id": "id48b5a264cc754f6fa51be5833f13afa3", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "The period\n\t\t\t\tcovered by the audit may not exceed 2 years from the date the claim involved\n\t\t\t\twas submitted to, or adjusted by, the PBM (or auditing entity)."}, "enum": {"#tail": "\n                    ", "#text": "(ee)"}, "@id": "ide3f7f79f7e644ab090cf42bdd0449829", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "The PBM (or\n\t\t\t\tauditing entity) shall have in place a written appeals process that affords the\n\t\t\t\tpharmacy a minimum of 60 days to respond to the auditor findings, shall include\n\t\t\t\tprocedures for appeals from preliminary reports and final reports related to\n\t\t\t\tsuch audit, and shall permit the pharmacy to introduce any documentation which\n\t\t\t\twould validate a claim contested in the audit until the final written decision\n\t\t\t\tis issued on appeal."}, "enum": {"#tail": "\n                    ", "#text": "(ff)"}, "@id": "id595eb56b789545f49b05fc03d195dc41", "#text": "\n                    "}], "#tail": "\n              ", "enum": {"#tail": "\n                  ", "#text": "(III)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "Assuring\n\t\t\t\tproper procedures"}, "#text": "\n                  ", "@id": "idc8fc40e358de452bbfad702ad7725792"}], "enum": {"#tail": "\n                ", "#text": "(i)"}, "header": {"#tail": "\n                ", "#text": "Proper audit\n\t\t\t\tprocedures"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "The following shall apply to each audit of a pharmacy\n\t\t\t\tconducted by or for the pharmacy benefits manager with respect to such\n\t\t\t\tprescription drug plan:"}, "#text": "\n                ", "@id": "id1e7d4f24991c43c1a2c50ab76c0d1674"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "term": {"#tail": ") and\n\t\t\t\tprovide a process for the generic effective rate to be appealed. For the\n\t\t\t\tpurposes of this rate or benchmark amount, the PBM shall utilize a\n\t\t\t\tpharmaceutical pricing benchmark published by a nationally available\n\t\t\t\tcompendium. The aggregate average reimbursement rate for generics (generic\n\t\t\t\teffective rate) shall be calculated using the actual amount paid to the\n\t\t\t\tpharmacy (typically the amount of reimbursement to the PBM plus the patient\n\t\t\t\tco-pay), excluding the dispensing fee, shall not be calculated solely according\n\t\t\t\tto the amount allowed by the plan, and shall include all generics dispensed,\n\t\t\t\tregardless of whether they are subject to MAC pricing.", "#text": "generic effective rate"}, "#text": "A PBM shall provide a particular\n\t\t\t\taggregate average reimbursement rate for generics or a maximum average discount\n\t\t\t\toff of an accepted pharmaceutical pricing benchmark for multi-source generics\n\t\t\t\tas a whole (often referred to as a "}, "enum": {"#tail": "\n                ", "#text": "(ii)"}, "header": {"#tail": "\n                ", "#text": "Business\n\t\t\t\tpractice predictability"}, "#text": "\n                ", "@id": "idf8126cab75f1432b919837166b09c3b4"}, {"#tail": "\n            ", "subclause": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "A PBM may not\n\t\t\t\ttransmit any personally identifiable utilization or claims data to a pharmacy\n\t\t\t\towned by a PBM if the plan enrollee has not voluntarily elected in writing or\n\t\t\t\tvia secure electronic means to fill that particular prescription at the\n\t\t\t\tPBM-owned pharmacy."}, "enum": {"#tail": "\n                  ", "#text": "(I)"}, "@id": "id3d3b22c501104155b4000128ff51cb0e", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "A PBM may not\n\t\t\t\trequire that a plan enrollee use a retail pharmacy, mail order pharmacy,\n\t\t\t\tspecialty pharmacy, or other pharmacy entity providing pharmacy services in\n\t\t\t\twhich the PBM has an ownership interest or that has an ownership interest in\n\t\t\t\tthe PBM or provide an incentive to a beneficiary to encourage the individual to\n\t\t\t\tuse a retail pharmacy, mail order pharmacy, specialty pharmacy, or other\n\t\t\t\tpharmacy entity providing pharmacy services in which the PBM has an ownership\n\t\t\t\tinterest or that has an ownership interest in the PBM, if the incentive is\n\t\t\t\tapplicable only to such\n\t\t\t\tpharmacies."}, "enum": {"#tail": "\n                  ", "#text": "(II)"}, "@id": "id181930d1b94d4eceb72fdbcc8db49ca7", "#text": "\n                  "}], "enum": {"#tail": "\n                ", "#text": "(iii)"}, "header": {"#tail": "\n                ", "#text": "Protecting\n\t\t\t\tpatient and claims related data"}, "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "A PBM shall adhere to the\n\t\t\t\tfollowing criteria when handling personally identifiable utilization and claims\n\t\t\t\tdata or other sensitive patient data:"}, "#text": "\n                ", "@id": "idf0bae04d85a546e8906394638e0b734a"}], "enum": {"#tail": "\n              ", "#text": "(B)"}, "header": {"#tail": "\n              ", "#text": "Requirements"}, "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "The\n\t\t\t\trequirements described in this subparagraph are as follows:"}, "#text": "\n              ", "@id": "id29A79A6AD6B54D60B2F6869C9373D997"}], "enum": {"#tail": "\n            ", "#text": "(7)"}, "header": {"#tail": "\n\t\t\t\t\t\t", "#text": "Pharmacy\n\t\t\t\tbenefits manager transparency and proper operations requirements"}, "#text": "\n            ", "@id": "idd327508c367b43de8129f5e0a8843cad"}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t", "@id": "id7cbdea08f636479bac211d2944502ee7"}, "#text": "\n        ", "@id": "idb8f3f3a2c7be40448182a47ec7124612"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ") is amended to\n\t\t\t read as follows:", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "Section\n\t\t\t 1860D\u201312(b) of the Social Security Act", "@value": "Social Security Act/s:1860D\u201312/ss:b"}, {"#tail": "\n          ", "@entity-type": "uscode", "#text": "\n              ", "external-xref": {"#tail": "\n            ", "@parsable-cite": "usc/42/1395w-112", "#text": "42 U.S.C. 1395w\u2013112(b)", "@legal-doc": "usc"}, "@value": "usc/42/1395w\u2013112/b"}], "@entity-type": "law-citation", "#text": "\n            "}}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Disclosure and\n\t\t\t regular update of prescription drug reimbursement"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n        ", "#text": "."}, "#tail": "\n\t\t\t", "paragraph": {"#tail": "\n          ", "@id": "idA2B21C5015BA4FF58CAC376514A86797", "enum": {"#tail": "\n            ", "#text": "(6)"}, "header": {"#tail": "\n            ", "#text": "Disclosure and\n\t\t\t\tregular update of prescription drug reimbursement"}, "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "Each contract\n\t\t\t\tentered into with a PDP sponsor under this part with respect to a prescription\n\t\t\t\tdrug plan offered by such sponsor shall provide that the sponsor or\n\t\t\t\tsubcontractor of such sponsor shall\u2014"}, "#text": "\n            ", "subparagraph": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "#text": "disclose to a\n\t\t\t\tpharmacy, at the time when a contract is offered, the methodology and actual\n\t\t\t\tper unit reimbursement amount for each covered drug for each such pharmacy;\n\t\t\t\tand"}, "enum": {"#tail": "\n              ", "#text": "(A)"}, "@id": "idC4F03595689E4A80B50BF688363A49DF", "#text": "\n              "}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "not less\n\t\t\t\tfrequently than once every 7 days, beginning with an initial update on January\n\t\t\t\t1 of each year\u2014"}, "enum": {"#tail": "\n              ", "#text": "(B)"}, "clause": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "update such\n\t\t\t\treimbursement amount to accurately reflect the market price of acquiring the\n\t\t\t\tdrug; and"}, "enum": {"#tail": "\n                ", "#text": "(i)"}, "@id": "id700026C0003E471E8B10707AF4945F40", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "disclose to each\n\t\t\t\tcontracted pharmacy such methodology and reimbursement\n\t\t\t\tamounts."}, "enum": {"#tail": "\n                ", "#text": "(ii)"}, "@id": "idCC3E2E2A18D348A59A301BD780248D50", "#text": "\n                "}], "#text": "\n              ", "@id": "id879B303ED89A4CCFB666F41A7AFB3E36"}]}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t", "@id": "idCDF986A56C584EA8A906D6B97DDCC8F5"}, "#text": "\n        ", "@id": "id9BA918AA5B1F4A0A9523B83D071E8538"}, {"#tail": "\n    ", "text": {"#tail": "\n\t\t\t", "#text": "The amendments made by this section shall apply to plan\n\t\t\t years beginning on or after January 1, 2015."}, "enum": {"#tail": "\n        ", "#text": "(c)"}, "header": {"#tail": "\n        ", "#text": "Effective\n\t\t\t date"}, "#text": "\n        ", "@id": "id37D6B7294E3C4AC48A6D94F3154BA09F"}], "#text": "\n      ", "@id": "id8f8bd790d28f44eb84f4b65f7d7ccb7b"}], "#text": "\n\t\t"}, "metadata": {"#tail": "\n", "dublinCore": {"{http://purl.org/dc/elements/1.1/}date": {"#tail": "\n", "#text": "2013-05-06"}, "{http://purl.org/dc/elements/1.1/}format": {"#tail": "\n", "#text": "text/xml"}, "{http://purl.org/dc/elements/1.1/}language": {"#tail": "\n", "#text": "EN"}, "#tail": "\n", "{http://purl.org/dc/elements/1.1/}title": {"#tail": "\n", "#text": "113 S867 IS: Medicare Prescription Drug Program Integrity and Transparency Act of 2013"}, "{http://purl.org/dc/elements/1.1/}rights": {"#tail": "\n", "#text": "Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain."}, "{http://purl.org/dc/elements/1.1/}publisher": {"#tail": "\n", "#text": "U.S. Senate"}, "#text": "\n"}, "#text": "\n"}}}